Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

Background: Several placebo controlled studies have demonstrated the efficacy of infliximab in inflammatory bowel disease (IBD) but the potential toxicity of this new biological compound has been less studied. Aim: To assess the use of infliximab in IBD in a population based cohort, with special emp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ljung, T, Karlén, P, Schmidt, D, Hellström, P M, Lapidus, A, Janczewska, I, Sjöqvist, U, Löfberg, R
Natura: Artigo
Lingua:Inglês
Pubblicazione: Copyright 2004 by Gut 2004
Soggetti:
Inflammatory Bowel Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774085/
https://ncbi.nlm.nih.gov/pubmed/15138212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.018515
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi